Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it had secured $15 million in Series E investment.
Existing investors Canaan Partners and New Leaf Venture Partners led the round.
WHAT IT DOES
The company provides technology to help employers secure lower drug pricing plans. Its software also allows sponsors to garner...
Truveris, a healthcare technology company focused cloud-based data analytics solutions for the $450 billion prescription benefits industry, today announced that the company has secured $25 million in a new round of funding to accelerate its growth strategies.
The Series D round was led by McKesson Ventures, and included Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and...
